{"id":"NCT00090220","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)","officialTitle":"Safety, Immunogenicity, and Efficacy of Gardasil (V501 (Human Papilloma Virus [Types 6, 11, 16, 18] Recombinant Vaccine) in Mid-Adult Women - The FUTURE III (Females United to Unilaterally Reduce Endo/Ectocervical Cancer) Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-06-16","primaryCompletion":"2009-05-21","completion":"2015-11-12","firstPosted":"2004-08-27","resultsPosted":"2010-02-01","lastUpdate":"2017-04-21"},"enrollment":3819,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Healthy Adult Female Participants","Prevention","Papillomavirus Infection","Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18"],"interventions":[{"type":"BIOLOGICAL","name":"Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Comparator: Placebo","otherNames":[]}],"arms":[{"label":"qHPV Vaccine in Base Study","type":"EXPERIMENTAL"},{"label":"Placebo in Base Study","type":"PLACEBO_COMPARATOR"}],"summary":"This study was conducted to assess the safety, immunogenicity, efficacy and long-term effectiveness of a vaccine being evaluated for the prevention of human papillomavirus (HPV) infection and disease in mid-adult women.","primaryOutcome":{"measure":"Incidence Rate of HPV 6/11/16/18 Related Persistent Infection, Genital Warts, VIN, VaIN, Vulvar Cancer, Vaginal Cancer, Cervical Dysplasia, Cervical AIS, and Cervical Cancer","timeFrame":"Up to 48 months (4 years) after the first dose of qHPV vaccine in the Base Study","effectByArm":[{"arm":"qHPV in Base Study","deltaMin":0.2,"sd":null},{"arm":"Placebo in Base Study","deltaMin":1.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"24 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":12},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["19493565","19652630","21629249","24391768","22518014","19935017","32184277","29074187"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":1890},"commonTop":["Injection site pain","Headache","Injection site swelling","Injection site erythema","Pyrexia"]}}